Navigation Links
Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
Date:3/2/2009

d treatment for an extended period of time; and VOLTAREN(R) gel, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at www.endo.com.

Important Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell securities. Endo Pharmaceuticals Holdings Inc. ("Endo") has filed a tender offer statement on Schedule TO with the Securities and Exchange Commission, and Indevus Pharmaceuticals, Inc. ("Indevus") has filed a solicitation/recommendation statement with respect to the tender offer. Investors and Indevus shareholders are strongly advised to read the tender offer statement (including the offer to purchase, letter of transmittal and other offer documents) and the related solicitation/recommendation statement because they contain important information. The offer to purchase, the related letter of transmittal and certain other offer documents, as well as the solicitation/recommendation statement, are available at no charge on the Securities and Exchange Commission's website at www.sec.gov. In addition, copies of these documents and other filings containing information about Indevus and the transaction can be obtained by all Indevus stockholders, without charge, by directing a request to Indevus Pharmaceuticals, Inc., Attention: General Counsel, 33 Hayden Avenue, Lexington, Massachusetts 02421-7966, by telephone at (781) 861-8444 or on Indevus' website, www.indevus.com.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
2. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
3. Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
4. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
5. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
6. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
7. Endo Pharmaceuticals Appoints William Montague to Board of Directors
8. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
10. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
11. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Senior Housing ... legend Lou Piniella, who managed the Seattle Mariners team ... Piniella will appear in television and digital advertising for ... living apartment communities, including several new communities slated to ... Bellevue, Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. ...
(Date:5/28/2015)... Mirada, CA (PRWEB) May 28, 2015 ... Anaheim clinic will now be offering Echocardiography Examinations ... will be performed by renowned Qualified Medical Examiner ... , The echocardiography test is a non-invasive and ... patients who are critically ill or have undergone ...
(Date:5/28/2015)... CompanionDx , a Houston-based genomic ... will present their integrated solution of next-generation sequencing ... American Society of Clinical Oncology (ASCO) in Chicago ... in a patient’s tumor via a small biopsy ... or somatic mutations. Pharmacogenomics testing establishes a clear ...
(Date:5/28/2015)... Newton, Mass. (PRWEB) May 28, 2015 ... a $17.5 million round of financing led by ... health solutions company dedicated to transforming health care by ... nation’s largest and most utilized network for exchanging medical ... its growing customer base, increase the breadth of its ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
Breaking Medicine News(10 mins):Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3
... Super Team in a Super City and run the 2009 Bank of ... Christopher & Dana Reeve Foundation. Registration deadline is approaching, so please apply ... ... (PRWEB) April 16, 2009 -- The Chicago Chapter of the Christopher ...
... during ALS Awareness Month, The ALS Association,s "ALS Across America" ... amyotrophic lateral sclerosis for their courageous battle with Lou Gehrig,s ... ... (Vocus)-- For the second consecutive year during ALS Awareness Month, ...
... race offers four routes for cyclists of all abilities LAKE ... WCBO ) is a corporate sponsor of the 19th ... May 16, 2009, the official start of the Oregon cycling ... Grand Ronde ensure that the American Lung Association fundraiser is ...
... AMDL, Inc., (NYSE Alternext US: ADL), ... the US, today announced financial results for the fourth ... months ended December 31, 2008, the Company demonstrated strong ... over 124%, reaching just over $33.6 million compared to ...
... LAUREL, N.J., April 15 MedQuist Inc. (Nasdaq: ... J. Golio as its new Chief Financial Officer. ... his role as MedQuist,s new CFO, Golio is responsible ... to financial planning, treasury, financial analysis, investor relations, tax, ...
... YORK, April 15 Lilly Pulitzer has always been ... colors to a worthy cause. To cap off the brand,s ... special project called A Colorful Cause ... Debra Messing, Marcia Cross, Angie Harmon, Bridget Moynahan, Gwyneth Paltrow, Catherine ...
Cached Medicine News:Health News:Attention Runners: Run the 2009 Bank of America Chicago Marathon with Team Reeve 2Health News:Attention Runners: Run the 2009 Bank of America Chicago Marathon with Team Reeve 3Health News:The ALS Association's 'ALS Across America' Focuses On Staying Positive and Involved 2Health News:The ALS Association's 'ALS Across America' Focuses On Staying Positive and Involved 3Health News:The ALS Association's 'ALS Across America' Focuses On Staying Positive and Involved 4Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 2Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 3Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 4Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 5Health News:AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets 6Health News:MedQuist Names Dominick J. Golio as Chief Financial Officer 2Health News:Lilly Pulitzer(R) Launches A Colorful Cause Celebrity Designed Collection for EBMRF 2
(Date:5/28/2015)... 28, 2015 Lungpacer Medical, Inc., a ... system announced today that it will be presenting ... Thursday, June 4, 2015 in New York City.  ... Eastern Time.   About Lungpacer Medical, ... stage medical device company pioneering the development of ...
(Date:5/28/2015)... FORT WORTH, Texas , May 28, 2015 /PRNewswire/ ... defines and segments the concerned market with analysis and ... million in 2014 and is estimated to reach $1,177.8 ... 2014 to 2019. Browse through the TOC ... the industry trends and segments, with help of various ...
(Date:5/28/2015)... May 28, 2015  Pharmaceutic Labs announces its ... section 503B of the FDA,s Drug Quality and ... company is subject to Current Good Manufacturing Practice ... according to the highest standards of CGMP 21 ... To continuously comply with FDA regulations and ensure ...
Breaking Medicine Technology:Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
Modular flow cytometer with all options....
... Ultracompact mobile/portable flow cytometer especially suited ... volumetric counting. The CyFlow allows to ... up to 2 fluorescence channels. Data ... performed with a built-in PC employing ...
... Compact mobile flow cytometer for any ... volumetric counting. The CyFlow SL analyzes ... combination with up to 3 fluorescence ... display is performed with a PC ...
Medicine Products: